Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Granular Cell Tumor of the Bile Duct.

Okada H, Izumi T, Uza N.

J Gastrointest Surg. 2019 May 8. doi: 10.1007/s11605-019-04254-5. [Epub ahead of print] No abstract available.

PMID:
31069639
2.

Hes1 plays an essential role in Kras-driven pancreatic tumorigenesis.

Nishikawa Y, Kodama Y, Shiokawa M, Matsumori T, Marui S, Kuriyama K, Kuwada T, Sogabe Y, Kakiuchi N, Tomono T, Mima A, Morita T, Ueda T, Tsuda M, Yamauchi Y, Sakuma Y, Ota Y, Maruno T, Uza N, Uesugi M, Kageyama R, Chiba T, Seno H.

Oncogene. 2019 May;38(22):4283-4296. doi: 10.1038/s41388-019-0718-5. Epub 2019 Jan 31.

PMID:
30705405
3.

Effect of mapping biopsy on surgical management of cholangiocarcinoma.

Yao S, Taura K, Okuda Y, Kodama Y, Uza N, Gouda N, Minamiguchi S, Okajima H, Kaido T, Uemoto S.

J Surg Oncol. 2018 Nov;118(6):997-1005. doi: 10.1002/jso.25226. Epub 2018 Sep 9.

PMID:
30196565
4.

Laminin 511 is a target antigen in autoimmune pancreatitis.

Shiokawa M, Kodama Y, Sekiguchi K, Kuwada T, Tomono T, Kuriyama K, Yamazaki H, Morita T, Marui S, Sogabe Y, Kakiuchi N, Matsumori T, Mima A, Nishikawa Y, Ueda T, Tsuda M, Yamauchi Y, Sakuma Y, Maruno T, Uza N, Tsuruyama T, Mimori T, Seno H, Chiba T.

Sci Transl Med. 2018 Aug 8;10(453). pii: eaaq0997. doi: 10.1126/scitranslmed.aaq0997.

PMID:
30089633
5.

Successful endoscopic removal of fractured guidewire fragments from a peripheral bile duct using a biliary stent delivery system and biopsy forceps.

Nishikawa Y, Uza N, Yamauchi Y, Fukuda A, Ueda Y, Kodama Y, Seno H.

Endoscopy. 2018 Oct;50(10):E279-E280. doi: 10.1055/a-0641-4989. Epub 2018 Jul 3. No abstract available.

PMID:
29969804
6.

Chemokine CXCL16 mediates acinar cell necrosis in cerulein induced acute pancreatitis in mice.

Sakuma Y, Kodama Y, Eguchi T, Uza N, Tsuji Y, Shiokawa M, Maruno T, Kuriyama K, Nishikawa Y, Yamauchi Y, Tsuda M, Ueda T, Matsumori T, Morita T, Tomono T, Kakiuchi N, Mima A, Sogabe Y, Marui S, Kuwada T, Okada A, Watanabe T, Nakase H, Chiba T, Seno H.

Sci Rep. 2018 Jun 11;8(1):8829. doi: 10.1038/s41598-018-27200-y.

7.

Association between homologous recombination repair gene mutations and response to oxaliplatin in pancreatic cancer.

Kondo T, Kanai M, Kou T, Sakuma T, Mochizuki H, Kamada M, Nakatsui M, Uza N, Kodama Y, Masui T, Takaori K, Matsumoto S, Miyake H, Okuno Y, Muto M.

Oncotarget. 2018 Apr 13;9(28):19817-19825. doi: 10.18632/oncotarget.24865. eCollection 2018 Apr 13.

8.

Choledochoduodenal Fistula during Chemotherapy with Brentuximab Vedotin for Methotrexate-associated Lymphoproliferative Disorder.

Eso Y, Uza N, Shirakawa K, Sawada K, Katsuragi K, Matsuura M, Seno H.

Intern Med. 2018 Aug 1;57(15):2203-2207. doi: 10.2169/internalmedicine.0557-17. Epub 2018 Mar 9.

9.

Utility of KRAS mutational analysis in the preoperative diagnosis of synchronous pancreatic cancer and intrahepatic cholangiocarcinoma: A case report.

Eso Y, Uza N, Yamagishi H, Imada K, Kimura Y, Masui T, Kodama Y, Seno H.

Medicine (Baltimore). 2017 Dec;96(50):e9217. doi: 10.1097/MD.0000000000009217.

10.

A case of cystic type intraductal papillary neoplasm of the bile duct diagnosed by SpyGlass DS, a novel peroral cholangioscopy.

Kuwada T, Shiokawa M, Uza N, Kodama Y.

Arab J Gastroenterol. 2017 Jun;18(2):118-119. doi: 10.1016/j.ajg.2017.05.014. Epub 2017 Jun 12. No abstract available.

PMID:
28619357
11.

Diagnostic performance of a new endoscopic scraper for malignant biliary strictures: a multicenter prospective study.

Sakuma Y, Kodama Y, Sogabe Y, Nakai Y, Yamashita Y, Mikami S, Kajimura K, Ikeda K, Tamaki H, Iwamoto S, Matsuda F, Fujita K, Uza N, Kawamura T, Uemoto S, Seno H, Chiba T, Yazumi S; Kyoto Pancreatobiliary Study Group.

Gastrointest Endosc. 2017 Feb;85(2):371-379. doi: 10.1016/j.gie.2016.07.060. Epub 2016 Aug 4.

PMID:
27497604
12.

Impact of EUS-FNA for preoperative para-aortic lymph node staging in patients with pancreatobiliary cancer.

Kurita A, Kodama Y, Nakamoto Y, Isoda H, Minamiguchi S, Yoshimura K, Kuriyama K, Sawai Y, Uza N, Hatano E, Uemoto S, Togashi K, Haga H, Chiba T.

Gastrointest Endosc. 2016 Sep;84(3):467-475.e1. doi: 10.1016/j.gie.2016.02.045. Epub 2016 Mar 10.

PMID:
26970011
13.

Pathogenicity of IgG in patients with IgG4-related disease.

Shiokawa M, Kodama Y, Kuriyama K, Yoshimura K, Tomono T, Morita T, Kakiuchi N, Matsumori T, Mima A, Nishikawa Y, Ueda T, Tsuda M, Yamauchi Y, Minami R, Sakuma Y, Ota Y, Maruno T, Kurita A, Sawai Y, Tsuji Y, Uza N, Matsumura K, Watanabe T, Notohara K, Tsuruyama T, Seno H, Chiba T.

Gut. 2016 Aug;65(8):1322-32. doi: 10.1136/gutjnl-2015-310336. Epub 2016 Mar 10.

PMID:
26964842
14.

Prognostic model for survival based on readily available pretreatment factors in patients with advanced pancreatic cancer receiving palliative chemotherapy.

Kou T, Kanai M, Yamamoto M, Xue P, Mori Y, Kudo Y, Kurita A, Uza N, Kodama Y, Asada M, Kawaguchi M, Masui T, Mizumoto M, Yazumi S, Matsumoto S, Takaori K, Morita S, Muto M, Uemoto S, Chiba T.

Int J Clin Oncol. 2016 Feb;21(1):118-25. doi: 10.1007/s10147-015-0864-x. Epub 2015 Jun 28.

PMID:
26123314
15.

Activation-Induced Cytidine Deaminase Contributes to Pancreatic Tumorigenesis by Inducing Tumor-Related Gene Mutations.

Sawai Y, Kodama Y, Shimizu T, Ota Y, Maruno T, Eso Y, Kurita A, Shiokawa M, Tsuji Y, Uza N, Matsumoto Y, Masui T, Uemoto S, Marusawa H, Chiba T.

Cancer Res. 2015 Aug 15;75(16):3292-301. doi: 10.1158/0008-5472.CAN-14-3028. Epub 2015 Jun 25.

16.

Non-functioning pancreatic neuroendocrine tumor accompanied with multiple liver metastases: remorseful case and literature review.

Hori T, Takaori K, Kawaguchi M, Ogawa K, Masui T, Ishii T, Nagata H, Narita M, Kodama Y, Uza N, Uemoto S.

JOP. 2014 Nov 28;15(6):622-5. doi: 10.6092/1590-8577/2861.

17.

Comparative outcomes between initially unresectable and recurrent cases of advanced pancreatic cancer following palliative chemotherapy.

Xue P, Kanai M, Mori Y, Nishimura T, Uza N, Kodama Y, Kawaguchi Y, Takaori K, Matsumoto S, Uemoto S, Chiba T.

Pancreas. 2014 Apr;43(3):411-6. doi: 10.1097/MPA.0000000000000050.

PMID:
24622071
18.

Neutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patients.

Xue P, Kanai M, Mori Y, Nishimura T, Uza N, Kodama Y, Kawaguchi Y, Takaori K, Matsumoto S, Uemoto S, Chiba T.

Cancer Med. 2014 Apr;3(2):406-15. doi: 10.1002/cam4.204. Epub 2014 Feb 12.

19.

Heparan sulfate on intestinal epithelial cells plays a critical role in intestinal crypt homeostasis via Wnt/β-catenin signaling.

Yamamoto S, Nakase H, Matsuura M, Honzawa Y, Matsumura K, Uza N, Yamaguchi Y, Mizoguchi E, Chiba T.

Am J Physiol Gastrointest Liver Physiol. 2013 Aug 1;305(3):G241-9. doi: 10.1152/ajpgi.00480.2012. Epub 2013 Jun 6.

20.

Endoscopic stent placement above the intact sphincter of Oddi for biliary strictures after living donor liver transplantation.

Kurita A, Kodama Y, Minami R, Sakuma Y, Kuriyama K, Tanabe W, Ohta Y, Maruno T, Shiokawa M, Sawai Y, Uza N, Yazumi S, Yoshizawa A, Uemoto S, Chiba T.

J Gastroenterol. 2013 Sep;48(9):1097-104. doi: 10.1007/s00535-012-0705-x. Epub 2013 Jan 17.

PMID:
23325164
21.

Risk of cancer in patients with autoimmune pancreatitis.

Shiokawa M, Kodama Y, Yoshimura K, Kawanami C, Mimura J, Yamashita Y, Asada M, Kikuyama M, Okabe Y, Inokuma T, Ohana M, Kokuryu H, Takeda K, Tsuji Y, Minami R, Sakuma Y, Kuriyama K, Ota Y, Tanabe W, Maruno T, Kurita A, Sawai Y, Uza N, Watanabe T, Haga H, Chiba T.

Am J Gastroenterol. 2013 Apr;108(4):610-7. doi: 10.1038/ajg.2012.465. Epub 2013 Jan 15.

PMID:
23318486
22.

Mediterranean mimicker.

Arasawa S, Nakase H, Ozaki Y, Uza N, Matsuura M, Chiba T.

Lancet. 2012 Dec 8;380(9858):2052. doi: 10.1016/S0140-6736(12)61377-4. No abstract available.

PMID:
23217869
23.

Toll-like receptor activation in basophils contributes to the development of IgG4-related disease.

Watanabe T, Yamashita K, Sakurai T, Kudo M, Shiokawa M, Uza N, Kodama Y, Uchida K, Okazaki K, Chiba T.

J Gastroenterol. 2013 Feb;48(2):247-53. doi: 10.1007/s00535-012-0626-8. Epub 2012 Jun 29.

PMID:
22744834
24.

Autoimmune pancreatitis exhibiting multiple mass lesions.

Shiokawa M, Kodama Y, Hiramatsu Y, Kurita A, Sawai Y, Uza N, Watanabe T, Chiba T.

Case Rep Gastroenterol. 2011 Sep;5(3):528-33. doi: 10.1159/000331799. Epub 2011 Sep 10.

25.

SR-PSOX/CXCL16 plays a critical role in the progression of colonic inflammation.

Uza N, Nakase H, Yamamoto S, Yoshino T, Takeda Y, Ueno S, Inoue S, Mikami S, Matsuura M, Shimaoka T, Kume N, Minami M, Yonehara S, Ikeuchi H, Chiba T.

Gut. 2011 Nov;60(11):1494-505. doi: 10.1136/gut.2010.221879. Epub 2011 Apr 6.

26.

Tacrolimus suppresses IL-12/IL23 p40 in Crohn's disease and heals fistulae refractory to anti-TNF-α therapy.

Nakase H, Matsuura M, Uza N, Chiba T.

Aliment Pharmacol Ther. 2011 Apr;33(8):979-80; author reply 980-1. doi: 10.1111/j.1365-2036.2011.04587.x. No abstract available.

27.

Importance of CXCL16 as a biomarker for granulocytapheresis in patients with Crohn's disease.

Nakase H, Uza N, Matsuura M, Chiba T.

Inflamm Bowel Dis. 2011 Oct;17(10):2211-2. doi: 10.1002/ibd.21657. Epub 2011 Mar 9. No abstract available.

PMID:
21391290
28.

Hemobilia: another complication associated with anti-thrombotic therapy.

Hiramatsu Y, Watanabe T, Shiokawa M, Kurita A, Matsuura M, Uza N, Kodama Y, Chiba T.

Clin J Gastroenterol. 2011 Feb;4(1):49-51. doi: 10.1007/s12328-010-0198-1. Epub 2010 Dec 18.

PMID:
26190622
29.

Role of heat shock protein 47 in intestinal fibrosis of experimental colitis.

Kitamura H, Yamamoto S, Nakase H, Matsuura M, Honzawa Y, Matsumura K, Takeda Y, Uza N, Nagata K, Chiba T.

Biochem Biophys Res Commun. 2011 Jan 14;404(2):599-604. doi: 10.1016/j.bbrc.2010.12.006. Epub 2010 Dec 6.

PMID:
21144841
30.

Immunosuppressive effects of tacrolimus on macrophages ameliorate experimental colitis.

Yoshino T, Nakase H, Honzawa Y, Matsumura K, Yamamoto S, Takeda Y, Ueno S, Uza N, Masuda S, Inui K, Chiba T.

Inflamm Bowel Dis. 2010 Dec;16(12):2022-33. doi: 10.1002/ibd.21318.

PMID:
20848491
31.

Possible involvement of T helper type 2 responses to Toll-like receptor ligands in IgG4-related sclerosing disease.

Akitake R, Watanabe T, Zaima C, Uza N, Ida H, Tada S, Nishida N, Chiba T.

Gut. 2010 Apr;59(4):542-5. doi: 10.1136/gut.2009.200972.

32.

The effect of proteasome inhibitor MG132 on experimental inflammatory bowel disease.

Inoue S, Nakase H, Matsuura M, Mikami S, Ueno S, Uza N, Chiba T.

Clin Exp Immunol. 2009 Apr;156(1):172-82. doi: 10.1111/j.1365-2249.2008.03872.x. Epub 2009 Feb 11.

33.

Upregulation of T-bet and tight junction molecules by Bifidobactrium longum improves colonic inflammation of ulcerative colitis.

Takeda Y, Nakase H, Namba K, Inoue S, Ueno S, Uza N, Chiba T.

Inflamm Bowel Dis. 2009 Nov;15(11):1617-8. doi: 10.1002/ibd.20861. No abstract available.

PMID:
19161180
34.

The effect of tacrolimus (FK-506) on Japanese patients with refractory Crohn's disease.

Tamaki H, Nakase H, Matsuura M, Inoue S, Mikami S, Ueno S, Uza N, Kitamura H, Kasahara K, Chiba T.

J Gastroenterol. 2008;43(10):774-9. doi: 10.1007/s00535-008-2229-y. Epub 2008 Oct 29.

PMID:
18958546
35.

Modulation of the Th1/Th2 balance by infliximab improves hyperthyroidism associated with a flare-up of ulcerative colitis.

Matsumura K, Nakase H, Yamamoto S, Yoshino T, Takeda Y, Kasahara K, Ueno S, Uza N, Chiba T.

Inflamm Bowel Dis. 2009 Jul;15(7):967-8. doi: 10.1002/ibd.20760. No abstract available.

PMID:
18942759
36.

Blockade of CXCL12/CXCR4 axis ameliorates murine experimental colitis.

Mikami S, Nakase H, Yamamoto S, Takeda Y, Yoshino T, Kasahara K, Ueno S, Uza N, Oishi S, Fujii N, Nagasawa T, Chiba T.

J Pharmacol Exp Ther. 2008 Nov;327(2):383-92. doi: 10.1124/jpet.108.141085. Epub 2008 Aug 20.

PMID:
18716065
37.

Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis.

Yamamoto S, Nakase H, Mikami S, Inoue S, Yoshino T, Takeda Y, Kasahara K, Ueno S, Uza N, Kitamura H, Tamaki H, Matsuura M, Inui K, Chiba T.

Aliment Pharmacol Ther. 2008 Sep 1;28(5):589-97. doi: 10.1111/j.1365-2036.2008.03764.x. Epub 2008 Jun 28.

38.

Importance of diagnosis of concomitant cytomegalovirus infection in patients with intestinal Behçet's disease.

Yoshino T, Nakase H, Mikami S, Nio M, Ueno S, Uza N, Ohmori K, Manabe T, Chiba T.

Inflamm Bowel Dis. 2008 Jun;14(6):877-8. doi: 10.1002/ibd.20400. No abstract available.

PMID:
18286611
39.

The effect of medical treatment on patients with fistulizing Crohn's disease: a retrospective study.

Uza N, Nakase H, Ueno S, Inoue S, Mikami S, Tamaki H, Matsuura M, Chiba T.

Intern Med. 2008;47(4):193-9. Epub 2008 Feb 15.

40.

Usefulness of quantitative real-time PCR assay for early detection of cytomegalovirus infection in patients with ulcerative colitis refractory to immunosuppressive therapies.

Yoshino T, Nakase H, Ueno S, Uza N, Inoue S, Mikami S, Matsuura M, Ohmori K, Sakurai T, Nagayama S, Hasegawa S, Sakai Y, Chiba T.

Inflamm Bowel Dis. 2007 Dec;13(12):1516-21.

PMID:
17828781
41.

Cross-primed CD8+ cytotoxic T cells induce severe Helicobacter-associated gastritis in the absence of CD4+ T cells.

Fukui T, Nishio A, Okazaki K, Kasahara K, Saga K, Tanaka J, Uza N, Ueno S, Kido M, Ohashi S, Asada M, Nakase H, Watanabe N, Chiba T.

Helicobacter. 2007 Oct;12(5):486-97.

PMID:
17760716
42.

Clinical features of Japanese patients with colonic angiodysplasia.

Ueno S, Nakase H, Kasahara K, Uza N, Kitamura H, Inoue S, Mikami S, Matsuura M, Chiba T.

J Gastroenterol Hepatol. 2008 Aug;23(8 Pt 2):e363-6. Epub 2007 Aug 27.

PMID:
17725595
43.

Education and Imaging. Gastrointestinal: ileal ulcers induced by non-steroidal anti-inflammatory drugs.

Matsuura M, Nakase H, Nakamura F, Ueda Y, Mikami S, Yoshino T, Ueno S, Uza N, Chiba T.

J Gastroenterol Hepatol. 2007 Aug;22(8):1346. No abstract available.

PMID:
17688672
44.

Open label trial of clarithromycin therapy in Japanese patients with Crohn's disease.

Inoue S, Nakase H, Matsuura M, Ueno S, Uza N, Kitamura H, Mikami S, Tamaki H, Kasahara K, Chiba T.

J Gastroenterol Hepatol. 2007 Jul;22(7):984-8.

PMID:
17608842
45.

Rescue therapy with tacrolimus for a patient with severe ulcerative colitis refractory to combination leukocytapheresis and high-dose corticosteroid therapy.

Nakase H, Mikami S, Matsuura M, Ueno S, Uza N, Inoue S, Kitamura H, Kasahara K, Yoshino T, Takeda Y, Chiba T.

Intern Med. 2007;46(11):717-20. Epub 2007 Jun 1.

46.

Henoch-Schönlein purpura in an elderly patient with unusual manifestation.

Uza N, Yazumi S, Tanabe K, Endo Y, Kodama Y, Matsumura Y, Sakashita H, Chiba T.

Endoscopy. 2007 Feb;39 Suppl 1:E35-6. Epub 2007 Feb 7. No abstract available.

PMID:
17285487
47.

Importance of early detection of cytomegalovirus infection in refractory inflammatory bowel disease.

Nakase H, Yoshino T, Ueno S, Uza N, Mikami S, Matsuura M, Chiba T.

Inflamm Bowel Dis. 2007 Mar;13(3):364. No abstract available.

PMID:
17206718
48.

Adminstration of PEG-Interferon to a Patient with Ulcerative Colitis and Chronic Hepatitis C Correlated with Reduced Colonic Inflammation and Reversal of Peripheral Th1/Th2 Ratios.

Kasahara K, Nakase H, Uza N, Ueno S, Matsuura M, Mikami S, Inoue S, Chiba T.

Case Rep Gastroenterol. 2007 Dec 21;1(1):157-61. doi: 10.1159/000112654.

49.

A case of ileal heterotopic pancreas with repeated melena.

Endo Y, Yazumi S, Kimura Y, Uza N, Matsuura M, Kodama Y, Nakase H, Chiba T.

Gastrointest Endosc. 2007 Jan;65(1):156-7; discussion 157. Epub 2006 Sep 20. No abstract available.

PMID:
17137856
50.

Caecal cancer associated with longstanding Crohn's disease.

Uza N, Nakase H, Kuwabara Y, Fujii S, Chiba T.

Lancet. 2006 Nov 18;368(9549):1842. No abstract available.

PMID:
17113433

Supplemental Content

Support Center